Hepatitis D: Spain does not fund a “promising” drug approved by Europe

It is estimated that there are between 5,000 and 7,000 patients with a disease associated with an increased risk of cirrhosis, end-stage liver disease, liver cancer and death. The Spanish Association for the Study of the Liver has the first patient registry and asks health to prioritize the inclusion of a new drug, approved by … Read more

Hepatitis D rebounds in Spain and doctors warn of lack of treatment

Hepatitis D recovers in Spain. They warn him of Spanish Society of Digestive Pathology (SEPD). After believing “virtually extinct” in the 90s – when this viral hepatitis had great clinical importanceaffecting 20% ​​of patients who have had a chronic infection by the hepatitis B virus-, currently, the prevalence of this disease is about 5%. This … Read more

La Jornada – Cuba develops an effective treatment for Alzheimer’s disease and Parkinson’s disease

A pioneer in the development of new technologies for the treatment of neurodegenerative diseases, the International Center for Neurological Restoration (Ciren) applies a molecule-based treatment for Alzheimer’s and Parkinson’s disease that prevents neurons from continuing the process of degeneration. Visiting Mexico, Héctor Vera Cuesta, director of Ciren, underlines the progress represented by the substance NeuroEPO, … Read more